GSK layoffs focused on PA and U.K. sites – not Triangle

While pharmaceutical giant GlaxoSmithKline is laying off employees in an ongoing restructuring of its research and development – the Triangle's 2,600 employees appear to be outside the focus of that effort. GSK has laid off employees at its two major R&D hubs – Collegeville, Pa., and Stevenage in the U.K. The move comes months after its new R&D head Hal Barron  announced a new strategy for his unit, prioritizing innovation and moving towards delivering a pipeline of medicines with a focus…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news